Menu
Share this

Pregnancy and Lactation Studies

Belimumab (BENLYSTA™) Pregnancy Registry

If you are pregnant and have been given belimumab within the four months prior to becoming pregnant and/or during pregnancy, you are eligible to participate in this global registry. The pregnant woman or one of her health care providers may contact the registry at:

Toll-free phone number (North America): +1 877 681 6296
Toll-free worldwide access fax number: +1 855 269 6182
Email address: belimumab.pregnancy@ppdi.com
Website: http://pregnancyregistry.gsk.com/belimumab.html

The BEXSERO® Pregnancy Registry

Pregnant women vaccinated with BEXSERO® within 30 days prior to the last menstrual period (LMP) or at any time during pregnancy and who are still currently pregnant are eligible to participate in this U.S. registry. The pregnant woman or one of her health care providers may contact the registry at:

Toll-free phone number: +1 877 413 4759
Toll-free fax number: +1 866 898 0564
Email address: BEXSEROPregnancyRegistry.SM@ppdi.com
Website: http://pregnancyregistry.gsk.com/bexsero.html

MENVEO® Vaccine Pregnancy Registry

Pregnant women vaccinated with MENVEO® within 28 days prior to conception or at any time during pregnancy, and who are currently pregnant, are eligible to participate in this U.S. registry. The pregnant woman or one of her health care providers may contact the registry at:

Toll-free phone number: +1 877 413 4759
Toll-free fax number:  +1 866 898 0564
Email address: MENVEOPregnancyRegistry.SM@ppdi.com
Website: http://pregnancyregistry.gsk.com/menveo.html

Oseltamivir Safety in Pregnancy

European-based, retrospective, observational, database study assessing the safety of oseltamivir exposure in pregnant women and their offspring.

Email address: Pregnancyand.InfantRegistriesSM@ppdi.com

T.A.P.P. (Take Action to Prevent Pregnancy) Pregnancy Monitoring Program for Acitretin

If you think you've become pregnant while taking Acitretin or within 3 years of stopping, contact the program at:

Toll-free phone number (US): +1 855 850 2138
Toll-free fax number (US): +1 855 850 2137
Website: http://www.tevagenerics.com/acitretin

Zanamivir Safety in Pregnancy

European-based, retrospective, observational, database study assessing the safety of zanamivir (Relenza inhalation powder) exposure in pregnant women and their offspring.

Email address: Pregnancyand.InfantRegistriesSM@ppdi.com

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2017 Pharmaceutical Product Development, LLC. All rights reserved.